ResearcherUniversity of ArizonaNo recent work listed
Amanda F. Baker
Matched on ORCID iD 0000-0002-0670-5381; OpenAlex author ID A5103147452. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 2 papers · 2015: none · 2016: 1 paper
Papers 5
- MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts. Co-author DOI 10.1371/journal.pone.0155289↗
- Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001). Co-author DOI 10.1007/s00280-014-2499-4↗
- Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0113586↗
- IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines. Last author DOI 10.1097/mpa.0b013e31823cdd10↗
- Management strategies in pancreatic cancer. Last author DOI 10.2146/ajhp100254↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Robert J. Gillies · 2 shared papers, 2014–2016 · strength 0.11
- Paper MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts. DOI 10.1371/journal.pone.0155289↗
- Paper Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. DOI 10.1371/journal.pone.0113586↗
- Pawel Swietach · 2 shared papers, 2014–2016 · strength 0.11
- Paper MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts. DOI 10.1371/journal.pone.0155289↗
- Paper Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. DOI 10.1371/journal.pone.0113586↗
- Charles P. Hart · 2 shared papers, 2014–2016 · strength 0.11
- Paper MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts. DOI 10.1371/journal.pone.0155289↗
- Paper Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. DOI 10.1371/journal.pone.0113586↗
- Tomislav Dragovich · 2 shared papers, 2011–2014 · strength 0.08
- Xiaomeng Zhang · 1 shared paper, 2016 · strength 0.07
- Katherine M. Block · 1 shared paper, 2012 · strength 0.04
- Christopher J. Campen · 1 shared paper, 2011 · strength 0.04
- Kate M. Bailey · 1 shared paper, 2014 · strength 0.04
- Xiaomeng Zhang · 1 shared paper, 2014 · strength 0.04
- Paul S. Ritch · 1 shared paper, 2014 · strength 0.04
- John J. Crowley · 1 shared paper, 2014 · strength 0.04
- Farshid Dayyani · 1 shared paper, 2014 · strength 0.04
- Manuel M. Hidalgo · 1 shared paper, 2014 · strength 0.04
- Peter J. Rosen · 1 shared paper, 2014 · strength 0.04
- Howard A. Burris Iiii · 1 shared paper, 2014 · strength 0.04
- Daniel D. Von Hoff · 1 shared paper, 2014 · strength 0.04
- Daniel A. Laheru · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.